Jump to content

Autologous and Allogeneic Cell Therapies: Comparison and Challenges

This infographic outlines the main stages involved in immune cell therapy product development. Depending on the approach used (autologous or allogeneic), there are unique challenges to consider when developing these therapies. 

Solutions to these challenges can be identified through leveraging data collected during product development enabling:

  • improvements in efficacy
  • prevention of adverse effects
  • their application to a broader range of indications

Read the full article to find out more.